Next Article in Journal
The Clinical Outcomes and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and HR+/HER2− Breast Cancer: A Multicenter Observational Study from Turkey
Previous Article in Journal
Correction: Będkowska et al. What We Know and Do Not Yet Know About the Canine Model of Lymphoma in Human Medicine—The Current State of Knowledge. Cancers 2025, 17, 596
 
 
Review

Article Versions Notes

Cancers 2025, 17(9), 1591; https://doi.org/10.3390/cancers17091591
Action Date Notes Link
article xml file uploaded 7 May 2025 14:34 CEST Original file -
article xml uploaded. 7 May 2025 14:34 CEST Update https://www.mdpi.com/2072-6694/17/9/1591/xml
article pdf uploaded. 7 May 2025 14:34 CEST Version of Record https://www.mdpi.com/2072-6694/17/9/1591/pdf
article html file updated 7 May 2025 14:35 CEST Original file https://www.mdpi.com/2072-6694/17/9/1591/html
Back to TopTop